The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain
Abstract
An increasing body of evidence indicates that: 1) the endocannabinoid anandamide (AEA) and other unsaturated N-acylethanolamines (NAEs), 2) 12-(S)-lipoxygenase (12-LOX) products of arachidonic acid, and 3) unsaturated N-acyldopamines (NADAs), act as endogenous ligands of transient receptor potential vanilloid type 1 (TRPV1) channels at intracellular binding sites. AEA is synthesized and released "on demand" in neurons from its membrane precursor, N-arachidonoyl-phosphatidylethanolamine, by an N-acyl-phosphatidylethanolamine-specific phospholipase D (NAPE-PLD), and is inactivated by intracellular hydrolysis by fatty acid amide hydrolase (FAAH), whereas catechol-O-methyl-transferase (COMT) was suggested to inactivate NADAs. However, it is not known whether these enzymes or 12-LOX co-localize to any extent with TRPV1 receptors in the brain. In this study we used immunohistochemical techniques (single peroxidase and double immunofluorescence staining), and analyzed the localization of the TRPV1 channel in mouse hippocampal and cerebellar neurons with respect to NAPE-PLD, FAAH, 12-LOX and COMT. Cycloxygenase-2 (COX-2), another putative AEA-degrading enzyme, was also studied. Co-localization between TRPV1 and either NAPE-PLD or FAAH, COX-2, 12-LOX and COMT was found in Ammon's horn (CA3) hippocampal pyramidal neurons and (with the exception of 12-LOX) in some Purkinje cells. At the cellular level, both anabolic and catabolic enzymes appeared as fine grains with immunoperoxidase labeling and were observed in the somatodendritic compartment of CA3 pyramidal cells as well as (with the exception of 12-LOX) in the cytoplasm of Purkinje neurons, in which FAAH and COX-2 immunoreactivities were, however, preferentially localized in the large extension of the dendritic arbor. Our data agree with the hypothesis that, in potential "endovanillergic" neurons, endogenous TRPV1 agonists, and AEA in particular, act as intracellular mediators by being produced from and/or degraded by the same mouse brain cells that express TRPV1 receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“COX-2 is primarily expressed postsynaptically and localizes to dendritic spines and dendrites in an expression pattern strikingly similar to that of FAAH (Cristino et al., 2008).”
From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Cristino et al., 2008
Citations
Cites
1 retracted
Ahluwalia, J., Yaqoob, M., Urbán, L., Bevan, S., & Nagy, I. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01550.x · Cited by 82
RetractedThe capsaicin receptor: a heat-activated ion channel in the pain pathway
Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. J. (1997) · Nature · doi:10.1038/39807 · Cited by 9,132
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,763
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Vanilloid (Capsaicin) Receptors and Mechanisms
SZALLASI, A., & Blumberg, P. M. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01403-0 · Cited by 1,903
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585
Cited by
Sorted by citations
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno‐Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,595
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,191
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970
Self-citationNeurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 698
Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 505
Marzo, V. D. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.02.010 · Cited by 381
Chávez, A. E., Chiu, C. Q., & Castillo, P. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2684 · Cited by 348
Remote Control of Neuronal Signaling
Rogan, S. C., & Roth, B. L. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003020 · Cited by 339
Phytocannabinoids as novel therapeutic agents in {CNS} disorders.
Hill, A. J., Williams, C. M., Whalley, B. J., & Stephens, G. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.002 · Cited by 312
Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo, V., & De Petrocellis, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0382 · Cited by 290
An introduction to the endocannabinoid system: from the early to the latest concepts
PETROCELLIS, L. D., & Marzo, V. D. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.013 · Cited by 260
Hot flash: TRPV channels in the brain
Kauer, J. A., & Gibson, H. E. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.006 · Cited by 235
The endocannabinoid system as a target for novel anxiolytic drugs
Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233
PETROCELLIS, L. D., & Marzo, V. D. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9177-z · Cited by 223
Biology of endocannabinoid synthesis system
Wang, J., & Ueda, N. (2008) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.12.002 · Cited by 190
Endocannabinoids in the retina: From marijuana to neuroprotection
Yazulla, S. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.07.002 · Cited by 188
Distribution of the Endocannabinoid System in the Central Nervous System
Hu, S. S., & Mackie, K. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_3 · Cited by 187
Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight
Marzo, V. D. (2010) · Nature Neuroscience · doi:10.1038/nn.2720 · Cited by 171
Ueda, N., Tsuboi, K., & Uyama, T. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.02.003 · Cited by 166
Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward
Volkow, N. D., Hampson, A. J., & Baler, R. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104615 · Cited by 159
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses
Kim, J., & Alger, B. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2517 · Cited by 149
From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
Pistis, M., & Melis, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980014 · Cited by 145
Lee, S.-H., Ledri, M., Toth, B., Marchionni, I., Henstridge, C. M., Dudok, B., Kenesei, K., Barna, L., Szabo, S. I., Renkecz, T., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4112-14.2015 · Cited by 133
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
Hermanson, D. J., Hartley, N. D., Gamble-George, J., Brown, N., Shonesy, B. C., Kingsley, P. J., Colbran, R. J., Reese, J., Marnett, L. J., & Patel, S. (2013) · Nature Neuroscience · doi:10.1038/nn.3480 · Cited by 126
“In support of this notion, FAAH, which is the primary metabolic regulator of AEA, is localized to the same postsynaptic cellular compartment as COX-2 43 .”
Luchicchi, A., & Pistis, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8299-0 · Cited by 130
Hermanson, D. J., Gamble‐George, J., Marnett, L. J., & Patel, S. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.006 · Cited by 121
Enzymological studies on the biosynthesis of N-acylethanolamines
Ueda, N., Tsuboi, K., & Uyama, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.08.010 · Cited by 112
Moreira, F. A., de Aguiar, D. C., Terzian, A. L. B., Guimarães, F. S., & Wotjak, C. T. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.046 · Cited by 113
Myöhänen, T. T., Schendzielorz, N., & Männistö, P. T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06723.x · Cited by 108
FAAH and anandamide: is 2-AG really the odd one out?
Marzo, V. D., & Maccarrone, M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.001 · Cited by 109
Giordano, C., Cristino, L., Luongo, L., Siniscalco, D., Petrosino, S., Piscitelli, F., Marabese, I., Gatta, L., Rossi, F., Imperatore, R., et al. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr328 · Cited by 100
TRPV1 in the Central Nervous System: Synaptic Plasticity, Function, and Pharmacological Implications
Edwards, J. G. (2014) · Springer eBooks · doi:10.1007/978-3-0348-0828-6_3 · Cited by 92
TRPV1 channels control synaptic plasticity in the developing superior colliculus
Maione, S., Cristino, L., Al, M., Georgiou, A. L., Starowicz, K., Salt, T. E., & Marzo, V. D. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.171900 · Cited by 88
Llorente, R., Llorente‐Berzal, A., Petrosino, S., Marco, E. M., Guaza, C., Prada, C., López‐Gallardo, M., Marzo, V. D., & Viveros, M. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20666 · Cited by 85
Role of endocannabinoids and endovanilloids in Ca2+ signalling
PETROCELLIS, L. D., & Marzo, V. D. (2009) · Cell Calcium · doi:10.1016/j.ceca.2009.03.003 · Cited by 80
Endocannabinoids: Effectors of glucocorticoid signaling
Balsevich, G., Petrie, G. N., & Hill, M. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.07.005 · Cited by 82
CB1 Cannabinoid Receptors Couple to Focal Adhesion Kinase to Control Insulin Release
Maleńczyk, K., Jazurek, M., Keimpema, E., Silvestri, C., Janikiewicz, J., Mackie, K., Marzo, V. D., Rędowicz, M. J., Harkany, T., & Dobrzyń, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478354 · Cited by 76
Starowicz, K., Makuch, W., Osikowicz, M., Piscitelli, F., Petrosino, S., Marzo, V. D., & Przewłocka, B. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.021 · Cited by 78
Sex‐dependent effects of endocannabinoid modulation of conditioned fear extinction in rats
Morena, M., Nastase, A. S., Santori, A., Cravatt, B. F., Shansky, R. M., & Hill, M. N. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15341 · Cited by 72
Neuronal populations mediating the effects of endocannabinoids on stress and emotionality
Häring, M., Guggenhuber, S., & Lutz, B. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.035 · Cited by 72
Fawley, J. A., Hofmann, M. E., & Andresen, M. C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0315-14.2014 · Cited by 65
Abdelhamid, R. E., Kovács, K. J., Nunez, M. G., & Larson, A. A. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.10.006 · Cited by 68
Lever, I. J., Robinson, M., Cibelli, M., Paule, C. C., Sántha, P., Yee, L., Hunt, S. P., Cravatt, B. F., Elphick, M. R., Nagy, I., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4071-08.2009 · Cited by 63
Chapter 1 Enzymatic Formation of Anandamide
Okamoto, Y., Tsuboi, K., & Ueda, N. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81001-7 · Cited by 62
Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system
Starowicz, K., & Przewłocka, B. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0392 · Cited by 60
Modulation of defensive behavior by transient receptor potential vanilloid type-1 (TRPV1) channels
Aguiar, D. C., Moreira, F. A., Terzian, A. L., Fogaça, M. V., Lisboa, S. F., Wotjak, C. T., & Guimaraes, F. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.026 · Cited by 57
TRPV1 acts as a synaptic protein and regulates vesicle recycling
Goswami, C., Rademacher, N., Smalla, K., Kalscheuer, V. M., Ropers, H., Gundelfinger, E. D., & Hucho, T. B. (2010) · Journal of Cell Science · doi:10.1242/jcs.065144 · Cited by 57
Physiological Role of Peroxisome Proliferator-Activated Receptors Type Alpha on Dopamine Systems
Melis, M., Carta, G., Pistis, M., & Banni, S. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312010012 · Cited by 56
Psychopharmacology of the endocannabinoids: far beyond anandamide
Pamplona, F. A., & Takahashi, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405357 · Cited by 61
Hennebelle, M., Zhang, Z., Metherel, A. H., Kitson, A. P., Otoki, Y., Richardson, C. E., Yang, J., Lee, K. S. S., Hammock, B. D., Zhang, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02914-7 · Cited by 58
Bennion, D. M., Jensen, T., Walther, C., Hamblin, J., Wallmann, A., Couch, J., Blickenstaff, J., Castle, M., Dean, L., Beckstead, S., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.018 · Cited by 52
Maione, S., Starowicz, K., Cristino, L., Guida, F., Palazzo, E., Luongo, L., Rossi, F., Marabese, I., de Novellis, V., & Marzo, V. D. (2009) · Journal of Neurophysiology · doi:10.1152/jn.91225.2008 · Cited by 51
Endogenous cannabinoid signaling at inhibitory interneurons
Younts, T. J., & Castillo, P. E. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.12.006 · Cited by 52
Hohmann, U., & Dehghani, F. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0015 · Cited by 50
Zhang, H., Hilton, D. A., Hanemann, C. O., & Zajicek, J. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00477.x · Cited by 50
Merrill, C. B., Friend, L. N., Newton, S. T., Hopkins, Z. H., & Edwards, J. G. (2015) · Scientific Reports · doi:10.1038/srep16176 · Cited by 49
Koch, M., Kreutz, S., Böttger, C., Grabiec, U., Ghadban, C., Korf, H., & Dehghani, F. (2010) · Hippocampus · doi:10.1002/hipo.20772 · Cited by 45
Friend, L. N., Weed, J., Sandoval, P. J., Nufer, T. M., Ostlund, I., & Edwards, J. G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0190-17.2017 · Cited by 47
Brain TRPV1: a depressing TR(i)P down memory lane?
Marzo, V. D., Gobbi, G., & SZALLASI, A. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.09.004 · Cited by 37
Hegyi, Z., Holló, K., Kis, G., Mackie, K., & Antal, M. (2012) · Glia · doi:10.1002/glia.22351 · Cited by 31
Ford, G. K., Kieran, S., Dolan, K., Harhen, B., & Finn, D. P. (2011) · Pain · doi:10.1016/j.pain.2011.07.014 · Cited by 32
Rojo-Bustamante, E., Abellanas, M. A., Clavero, P., Thiolat, M.-L., Li, Q., Luquín, M. R., Bézard, E., & Aymerich, M. S. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.06.019 · Cited by 30
Placzek, E. A., Okamoto, Y., Ueda, N., & Barker, E. L. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.047 · Cited by 29
Cerebellar Endocannabinoids: Retrograde Signaling from Purkinje Cells
Marcaggi, P. (2014) · The Cerebellum · doi:10.1007/s12311-014-0629-5 · Cited by 27
Carletti, F., Gambino, G., Rizzo, V., Ferraro, G., & Sardo, P. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.02.005 · Cited by 27
TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis
Paltser, G., Liu, X. J., Yantha, J., Winer, S., Tsui, H., Wu, P., Maezawa, Y., Cahill, L. S., Laliberté, C. L., Ramagopalan, S. V., et al. (2013) · Molecular Medicine · doi:10.2119/molmed.2012.00329 · Cited by 26
Grabiec, U., Koch, M., Kallendrusch, S., Kraft, R., Hill, K., Merkwitz, C., Ghadban, C., Lutz, B., Straiker, A. J., & Dehghani, F. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.023 · Cited by 25
Navarrete, C. M., Pérez, M., de Vinuesa, A. G., Collado, J. A., Fiebich, B. L., Calzado, M. A., & Muñóz, E. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.014 · Cited by 24
Light, A. R., Vierck, C. J., & Light, K. C. (2011) · Europe PMC (PubMed Central) · Cited by 22
Sampaio, M. D. F. D. S., de Paiva, Y. B., Sampaio, T. B., Pereira, M. G., & Coimbra, N. C. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13997 · Cited by 28
Antonazzo, M., Botta, M. F., Bengoetxea, H., Ruíz-Ortega, J. Á., & Morera‐Herreras, T. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.06.012 · Cited by 23
Comparative Effects of Heterologous TRPV1 and TRPM8 Expression in Rat Hippocampal Neurons
Crawford, D. C., Moulder, K. L., Gereau, R. W., Story, G. M., & Mennerick, S. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008166 · Cited by 23
Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice
Pamplona, F. A., Menezes‐de‐Lima, O., & Takahashi, R. N. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.050 · Cited by 22
Cyclooxygenase-2 inhibition prevents stress induced amygdala activation and anxiety-like behavior
Morgan, A., Gaulden, A. D., Altemus, M., Williford, K. M., Centanni, S. W., Winder, D. G., & Patel, S. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.07.046 · Cited by 17
Sagheddu, C., Torres, L. H., Marcourakis, T., & Pistis, M. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.588660 · Cited by 15
Endocannabinoid-Binding Receptors as Drug Targets
Gómez‐Cañas, M., Rodríguez‐Cueto, C., Satta, V., Hernández-Fisac, I., Navarro, E., & Fernández‐Ruíz, J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2728-0_6 · Cited by 17
Nagy, B., Fedonidis, C., Photiou, A., Wahba, J., Paule, C. C., Ma, D., Buluwela, L., & Nagy, I. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.047 · Cited by 18
Reguero, L., Puente, N., Elezgarai, I., Ramos, A., Gerrikagoitia, I., Bueno‐López, J., Doñate-Oliver, F., & Grandes, P. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1174-x · Cited by 17
Seillier, A., & Giuffrida, A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.032 · Cited by 16
Mizuno, I., & Matsuda, S. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00246-y · Cited by 17
Merrill, C. B., McNeil, M., Williamson, R. C., Poole, B., Nelson, B., Sudweeks, S. N., & Edwards, J. G. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.012 · Cited by 14
Canduela, M.-J., Mendizabal-Zubiaga, J., Puente, N., Reguero, L., Elezgarai, I., Ramos-Uriarte, A., Gerrikagoitia, I., & Grandes, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119401 · Cited by 13
Roles of N-Acylethanolamines in Brain Functions and Neuropsychiatric Diseases
Pistis, M., & Muntoni, A. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_11 · Cited by 12
Friend, L. N., Williamson, R. C., Merrill, C. B., Newton, S. T., Christensen, M. T., Petersen, J., Wu, B., Ostlund, I., & Edwards, J. G. (2019) · Molecules · doi:10.3390/molecules24071306 · Cited by 12
Czikora, Á., Lizanecz, E., Boczán, J., Daragó, A., Papp, Z. L., Edes, I. F., & Tóth, A. (2012) · Life Sciences · doi:10.1016/j.lfs.2011.12.016 · Cited by 10
Cristino, L., Imperatore, R., & Marzo, V. D. (2017) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2017.05.003 · Cited by 9
Durydivka, O., Palivec, P., Gazdarica, M., Mackie, K., Blahoš, J., & Kuchař, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-58845-7 · Cited by 9
5-Lipoxygenase in mouse cerebellar Purkinje cells
Chen, H., Dzitoyeva, S., & Manev, H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.019 · Cited by 8
Marzo, V. D. (2011) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0023403 · Cited by 8
Bertacchini, G. L., Sonego, A. B., Lisboa, S. F. D. S., Lagatta, D. C., & Resstel, L. B. M. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17384 · Cited by 5
Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS
Kouchaeknejad, A., van der Walt, G., de Donato, M. H., & Puighermanal, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115829 · Cited by 6
Bialecki, J., Weilinger, N. L., Lohman, A. W., Vecchiarelli, H. A., Robinson, J. H. B., Huguet, J. E., Medizabal-Zubiaga, J., Werner, A. C., Grandes, P., Teskey, G. C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/263640 · Cited by 5
Cannabinoids and Synaptic Transmission in the Cerebellum
Myoga, M. H., & Regehr, W. G. (2012) · Springer eBooks · doi:10.1007/978-3-030-23810-0_39 · Cited by 3
PETROCELLIS, L. D., & Marzo, V. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-420126-2.00005-5 · Cited by 3
Endocannabinoid Modulation in Headache: Mechanisms, Models, and Translational Therapies
Wen, J., & Zhang, Y. (2026) · Cells · doi:10.3390/cells15040331 · Cited by 2
Anandamide and Other Acylethanolamides
Petrosino, S., & Marzo, V. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-30378-9_5 · Cited by 2
Wang, F.-Y., Wei, L., Wang, P., Chen, W., Chen, Z., Zhou, Z.-Q., Zhu, G., Gong, Q., Qin, L.-P., Yang, L., et al. (2026) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2026.118409 · Cited by 1
Temperature-Sensitive Transient Receptor Potential Channels as Ionotropic Cannabinoid Receptors
Marzo, V. D., & PETROCELLIS, L. D. (2012) · The Receptors · doi:10.1007/978-1-4614-4669-9_8 · Cited by 1
Dutta, R. (2021) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001049 · Cited by 1
TRPV1 in Neuropathic Pain and Neurological and Neuropsychiatric Disorders
Palazzo, E., Starowicz, K., Maione, S., & Marzo, V. D. (2010) · Wiley eBooks · doi:10.1002/9780470588284.ch10
Metadata
- Authors
- Cristino, L., Starowicz, K., De Petrocellis, L., Morishita, J., Ueda, N., Guglielmotti, V., & Di Marzo, V.
- Affiliations
- Institute of Applied Science and Intelligent Systems (IT)
- Istituto di Chimica Biomolecolare (IT)
- Kagawa University (JP)
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 151
- Issue
- 4
- Pages
- 955-968
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2024356032
- Cited by
- 115
- References
- 70
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 11 · 2016: 3 · 2015: 5 · 2014: 8 · 2013: 8 · 2012: 11
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- anandamide, endocannabinoids, endovanilloids, TRPV1, fatty acid amide hydrolase, 12-lipoxygenase, catechol-O-methyltransferase, cyclooxygenase-2, N-acylethanolamines, hippocampus, cerebellar cortex, Purkinje cells, CA3 pyramidal cells, enzyme colocalization
- MeSH terms
- Fatty Acid Amide Hydrolases, Amidohydrolases, Animals, Arachidonate 12-Lipoxygenase, Catechol O-Methyltransferase, Cerebellar Cortex, Glutamate Decarboxylase, Hippocampus, Male, Neurons, Phospholipase D, TRPV Cation Channels, Mice, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review